Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Notice to Our Valued Users

Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.

We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.

We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.

If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Urology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured

Published in Urology

Expert Opinion / Commentary · December 05, 2022

2022 Top Story in Urology: Evolution of Tools for the Selection of Medical Applicants

Written by

Louis R. Kavoussi MD

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

References

story of the week

Contribution of Gleason Pattern 4 Prostate Tissue to Blood PSA Levels

Urology · January 09, 2023

updated
story of the week

The Impact of Local Staging of Prostate Cancer Determined on MRI or DRE at Time of Radical Prostatectomy on Progression-Free Survival

Urol. Oncol · January 05, 2023
featured

Treatment Decision Regret in Long-Term Prostate Cancer Survivors After Radical Prostatectomy

BJU Int · January 05, 2023
story of the week

Systemic Inflammation Response Index as an Independent Predictive Factor for Survival Outcomes in Patients With Bladder Cancer

Urol. Oncol · January 04, 2023
featured

Multiple Recurrences and Disease Progression in Patients With Intermediate-Risk NMIBC

Urology · January 04, 2023
featured

Intracavernosal Injection of Botulinum Toxin in the Treatment of Erectile Dysfunction

Urology · January 03, 2023

updated
featured

Median 5-Year Outcomes of Primary Focal IRE for Localised Prostate Cancer

BJU Int · December 29, 2022
featured

Log Odds of Positive Lymph Nodes as an Independent Predictor of Overall Survival After Radical Cystectomy in Patients With Urothelial Bladder Cancer

Clin Genitourin Cancer · December 29, 2022
featured

Shifting Risk-Stratified Early Prostate Cancer Detection to a Primary Healthcare Setting

BJU Int · December 28, 2022
featured

Relationship Between the Number of Lymph Nodes Dissected and Prognosis in Patients With MIBC in the Era of Neoadjuvant Chemotherapy

Int. J. Urol. · December 27, 2022

updated
featured

Novel Potential Risk Factors for Postoperative Complications Following Primary Hypospadias Repair

Urology · December 27, 2022

Notice to Our Valued Users

2022 Top Story in Urology: Evolution of Tools for the Selection of Medical Applicants

Additional Info

Further Reading

Contribution of Gleason Pattern 4 Prostate Tissue to Blood PSA Levels

The Impact of Local Staging of Prostate Cancer Determined on MRI or DRE at Time of Radical Prostatectomy on Progression-Free Survival

Treatment Decision Regret in Long-Term Prostate Cancer Survivors After Radical Prostatectomy

Systemic Inflammation Response Index as an Independent Predictive Factor for Survival Outcomes in Patients With Bladder Cancer

Multiple Recurrences and Disease Progression in Patients With Intermediate-Risk NMIBC

Intracavernosal Injection of Botulinum Toxin in the Treatment of Erectile Dysfunction

Median 5-Year Outcomes of Primary Focal IRE for Localised Prostate Cancer

Log Odds of Positive Lymph Nodes as an Independent Predictor of Overall Survival After Radical Cystectomy in Patients With Urothelial Bladder Cancer

Shifting Risk-Stratified Early Prostate Cancer Detection to a Primary Healthcare Setting

Relationship Between the Number of Lymph Nodes Dissected and Prognosis in Patients With MIBC in the Era of Neoadjuvant Chemotherapy

Novel Potential Risk Factors for Postoperative Complications Following Primary Hypospadias Repair

Recently Updated